M1238
HCPCSDoc 2nd recom hzv 2-6 mo int
Official HCPCS Level II long descriptor
Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
HCPCS Level II code M1238 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Doc 2nd recom hzv 2-6 mo int
Added to HCPCS: 2024-01-01
Nearby codes in M1
- M1230Pt hcv rctv aby no f/u tst
- M1231Pt hcv tst no reactive res
- M1232Pt hcv tst reactive result
- M1233Pt no hcv aby or result
- M1234Pt hcv rctv aby f/u neg
- M1235Doc pt hcv aby rna tst
- M1236Baseline mrs > 2
- M1237Pt rsn no scrn
- M1239Pt no resp heard
- M1240Pt no resp best int
- M1241Pt no resp seen as person
- M1242Pt no resp imprt to me
- M1243Pt othr thn true heard
- M1244Pt othr thn true best int
- M1245Pt othr thn true person
- M1246Pt othr thn true imprt to me
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.